Sildenafil increases serum testosterone levels by a direct action on the testes
Open Access
- 18 September 2013
- Vol. 1 (6) , 913-918
Abstract
Phosphodiesterase‐5‐inhibitors, such as sildenafil, increase intracavernosal cyclic guanosine monophosphate levels, which results in corporal smooth muscle relaxation and penile erection. Here, we determined the effects of sildenafil administration on the hypothalamic‐pituitary‐gonadal axis in men with erectile dysfunction and low testosterone levels. The Testosterone and Erectile Dysfunction trial (ClinicalTrials.gov # NCT00512707) initially administered an optimized dose of sildenafil to 140 men, aged 40–70 years with erectile dysfunction, low serum total testosterone (p < 0.001) and 110 pmol/L (31.7 pg/mL; p < 0.001) in total and free testosterone levels respectively. This was accompanied by parallel increases in serum DHT (0.17 nmol/L; 4.9 ng/dL; p < 0.001) and oestradiol (14 pmol/L; 3.7 pg/mL; p < 0.001) and significant suppression of luteinizing hormone (change −1.3 units/L; p = 0.003) levels, suggesting a direct effect at the testicular level. Androstenedione and oestrone increased by 1.3 nmol/L (38 ng/dL; p = 0.011) and 10.7 pmol/L (2.9 pg/mL; p = 0.012), respectively, supporting a possible effect of sildenafil on adrenal steroidogenesis. In conclusion, sildenafil administration was associated with increased testosterone levels likely ascribable to a direct effect on the testis.Keywords
This publication has 35 references indexed in Scilit:
- Transient Rise of Serum Testosterone Level After Single Sildenafil Treatment of Adult Male RatsThe Journal of Sexual Medicine, 2012
- Risk Factors Associated With Cardiovascular Events During Testosterone Administration in Older Men With Mobility LimitationThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2012
- Reference Ranges for Testosterone in Men Generated Using Liquid Chromatography Tandem Mass Spectrometry in a Community-Based Sample of Healthy Nonobese Young Men in the Framingham Heart Study and Applied to Three Geographically Distinct CohortsThe Journal of Clinical Endocrinology & Metabolism, 2011
- Sildenafil treatment in vivo stimulates Leydig cell steroidogenesis via the cAMP/cGMP signaling pathwayAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Adverse Events Associated with Testosterone AdministrationNew England Journal of Medicine, 2010
- Effects of Testosterone on Muscle Strength, Physical Function, Body Composition, and Quality of Life in Intermediate-Frail and Frail Elderly Men: A Randomized, Double-Blind, Placebo-Controlled StudyThe Journal of Clinical Endocrinology & Metabolism, 2010
- Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of PhysiciansAnnals of Internal Medicine, 2009
- Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysisAnnals of Internal Medicine, 2009
- Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levelsClinical Endocrinology, 2004
- Endocrine, psychological and genital response to sexual arousal in menPsychoneuroendocrinology, 1987